RA Capital — Full Portfolio

A pharmaceutical company developing treatments for serious chronic diseases with a focus on long-term health solutions and improving medicine access and affordability globally.

BiotechDigital HealthHealthtech

Co-investorsACAccess BiotechnologyBABain Capital Life SciencesRIRidgeback CapitalOXOxford Bioscience Partners

Dignify Therapeutics is developing drug programs that induce on-demand defecation and urination to treat functional bowel and bladder disorders, including incontinence and retention associated with neurological conditions and aging.

BiotechDigital HealthMedical DevicesResearch Triangle Park, US

Edward C Burgard(Executive Officer, Director, Promoter)Karl Thor(Chief Scientific Officer)inBWBenny Ward(Executive Officer, Director, Promoter)inAnthony DiTonno(CEO)Ed Burgard(President)Jeff Welch(Chief Operating Officer)

Co-investorsESEshelman Ventures, LLCMOMontreux Equity Partners

The page presented is corporate content for Novartis, a pharmaceutical company that develops medicines across areas such as multiple sclerosis, cardiovascular disease, and oncology.

BiotechHealthtechSan Diego, US

ASArthur Suckow, Ph.D.(Founder)in

Co-investorsACAccess BiotechnologyEXExSight VenturesJAJanus Henderson Investors

Dynelectro commercializes solid oxide electrolysis (SOEC) systems for industrial hydrogen production and energy storage, with modular platforms scaling from 250 kW to multi-megawatt capacity.

CleantechDeep TechEnergyHardware

SHSøren Højgaard Jensenin

Co-investorsTHThe Footprint FirmVSVsquared VenturesYAYara Growth VenturesEUEuropean Investment BankPSPSV

A digital health resource platform providing medical professionals with educational information and clinical resources about transthyretin amyloid cardiomyopathy (ATTR-CM) and related cardiac and neurological conditions.

BiotechDigital HealthHealthtechSan Francisco, US

NKNEIL KUMAR(Executive Officer, Director)JONATHAN FOX(Executive Officer)UMA SINHA(Executive Officer)CHRISTINE SIU(Executive Officer)HOYOUNG HUH(Director)ERIC AGUIAR(Director)

Co-investorsAIAisling CapitalFOForesite CapitalVIViking GlobalVIViking Global Investors

Electra Therapeutics develops antibody therapeutics targeting Signal Regulatory Protein (SIRP) for immunological diseases and cancer treatment.

BiotechHealthtechMedical DevicesSouth San Francisco, US

ARAdam Rosenthal(Co-founder and former CEO; Director)inQuehuong (Kathy) Dong, Pharm.D.(Executive Officer, Director)Kathy Dong(President, Chief Executive Officer and Director)in

BoardBeth Seidenberg, M.D.(Director)Thomas Geninatti, Ph.D.(Director)Carl Gordon, Ph.D.(Director)

Co-investorsHBHBM Healthcare InvestmentsHBHBM PartnersOROrbiMedWEWestlake Village BioPartnersKLKleiner PerkinsNVNVIDIA

Elektrofi is a biotech company developing an ultra-high concentration microparticle formulation platform that enables subcutaneous delivery of biologic medicines such as monoclonal antibodies.

BiotechDeep TechHealthtechMedical DevicesBoston, US

Chase Coffman(Chief Executive Officer & Co-founder)inSam Huang(Director)Jason Norris(Co-founder)Charles L. Cooney(Director)Andrew Goldberg(Director)Constatine Chinoporos(Director)

Co-investorsBIBiotechnology Value FundNONovo HoldingsCACatalio Capital Management, LPCHCharlotte Angel FundGEGeneral CatalystSRSR One Capital Management+1 more

Element Biosciences develops biological analysis platforms and DNA sequencing tools for scientists and research institutions.

BiotechDeep TechHardwareMedical Devices

Matthew Kellinger(Founder)Michael Previte(Founder)Molly He(Founder)

Co-investorsDRDraper AssociatesFOForesite CapitalFUFusionTSTSVCVEVenrockWEWellington Management

Empatica offers an FDA-cleared health monitoring platform combining medical wearables and digital biomarkers to collect continuous, clinical-quality health data from daily life.

AI & Machine LearningDigital HealthHealthtechMedical DevicesCambridge, US

RPRosalind Picard(Founder)inMLMatteo Lai(Executive Officer, Director)inSTSimone Tognetti(Director)inLPLen Picard(Executive Officer, Director)inMario Scuderi(Director)

Co-investorsBLBlack Opal VenturesCDCDP Venture CapitalSASanofi VenturesINInnogest Capital

Evodia is a Danish aroma company that uses precision fermentation with proprietary yeast strains to produce monoterpenes, the natural molecules behind flavor and aroma, as a sustainable alternative to plant-derived ingredients.

BiotechCleantechClimate TechDeep TechFoodTechCopenhagen, DK

Co-investorsNONordic Foodtech VCPIPINCTHThe March Group

Eyconis is a clinical-stage biotechnology company developing long-acting ophthalmic therapies for serious eye diseases such as wet age-related macular degeneration and diabetic macular edema using the TransCon technology platform.

BiotechDigital HealthMedical DevicesRedwood City, US

ECEmmett Cunningham(Executive Officer, Director)inMark Bachleda(Executive Officer, Director)inRVRobert Vitti(Executive Officer)inOSOliver Stauch(Executive Officer)inCWConrad Wang(Director)in

BoardDEDan Estes(Director)in

Co-investorsFRFrazier Life SciencesHEHealthQuest CapitalVEvenBio PartnersVEvenBio Global Strategic

Familiar Machines develops emotionally intelligent physical AI, including the underlying models and hardware, for consumer home use.

AI & Machine LearningConsumerRoboticsWoburn, US

CAColin Angle(CEO & Co-founder)inCJChris Jones(CRDO & Co-founder)inIRIra Renfrew(C2PO & Co-founder)in

Co-investorsDAData Point Capital

Farcast develops advanced satellite communication user terminals with flat panel phased array antennas that electronically track satellite movement for reduced size, weight, power, and cost.

Advanced ManufacturingHardwareSpace TechSan Francisco, US

SESiamak Ebadi(Founder)inSteph Wang(Head of Operations)

BoardDBDavid Byrd(Director)inGuido Jouret(Director)

Co-investorsBLBlueYard CapitalFIFifty YearsGAGarage CapitalJUJude GomilaMAMaC Venture CapitalY Y Combinator+3 more

Forge Biologics is a US-based gene therapy CDMO (contract development and manufacturing organization) offering AAV manufacturing services, technologies, and infrastructure.

Advanced ManufacturingBiotechHealthtechMedical DevicesGrove City, US

TJTimothy J. Miller(Executive Officer, Director)in

BoardChris Garabedian(Director)inMMMolly McCartin(Director)in

Co-investorsAIAisling CapitalDRDrive Capital

Frontier is a drug discovery company developing small-molecule covalent drugs aimed at previously undruggable protein targets across the proteome.

AI & Machine LearningBiotechSouth San Francisco, US

CVChris Varma, Ph.D.(Executive Officer, Director)CVChris Varma(Co-founder, Chairman and CEO)inJim Winkler(Executive Officer)JHJohannes Hermann, Ph.D.(Executive Officer)KWKevin Webster(Executive Officer)inGregory Chow(Executive Officer)

Co-investorsBEBerkeley CatalystDCDCVC (Data Collective)DRDroia VenturesFEFelicis VenturesMPMPM BioImpactDCDCVC Bio+2 more

Gameto develops cell therapy and reproductive technologies to treat infertility and improve women's health outcomes.

BiotechFemTechHealthtechMedical DevicesAustin, US

DTDina Turner(Co-founder & Chief Executive Officer)inMVMartin Varsavsky(Co-founder & Chairman)inDRDina Radenkovic(Founder)inMartín Varsavsky(Founder)

BoardDPDusan Perovic(Director)inDMDylan Morris(Director)in

Co-investorsBOBold Capital PartnersDEDeviation CapitalFJFJ LabsFUFuture VenturesGAGaingelsINIngeborg Investments+19 more

GentiBio develops engineered regulatory T-cell (EngTreg) therapies designed to reset the immune system and treat autoimmune and acute inflammatory diseases.

BiotechHealthtechMedical Devices

JBJane Buckner(Scientific Co-founder (President, Benaroya Research Institute))CPChandra Patel(Co-founder & SVP, Research and Development Operations)inDRDavid Rawlings(Scientific Co-founder and Senior Scientific Advisor)ASAndy Scharenberg(Scientific Co-founder, SAB Chair)AWAndy Walker(President and CEO)inTWTom Wickham(Chief Scientific Officer)

Co-investorsNONovartis Venture FundOROrbiMedJDJDRF T1D Fund

GIVAX is a biotechnology company focused on vaccine development.

BiotechHealthtech

JPJohn Patton(Scientific Co-Founder)inMBMario Barro(President & CEO)in

Global Blood Therapeutics was a South San Francisco biopharmaceutical company founded in 2011 focused on treatments for sickle cell disease.

South San Francisco, US

JSJohn Schembri(Executive Officer)inTed W. Love(Executive Officer, Director)in

BoardKSKevin Starr(Director)inCharles Homcy, M.D.(Director)

Co-investorsAIAisling CapitalAVAvoro Capital AdvisorsRIRidgeback CapitalTHThird Rock VenturesWEWellington Management

Halda provides AI agents for higher-education enrollment, including a campaign agent for personalized email outreach, a website conversion agent, and an always-on recruiter agent that responds to students via text, email, voice, and WhatsApp.

AI & Machine LearningEdTechSaaSProvo, US

Lance Hydrick(Executive Officer, Director)Dallin Palmer(Director)

BoardSKSid Krommenhoek(Director)in

Co-investorsALAlbum VCFRFrazier Life SciencesKIKickstart

BiotechMedical DevicesNew Haven, US

Scott Phillips(Executive Officer)in

BoardTSTim Shannon(Manager)inLRLiam Ratcliffe(Manager)in

Co-investorsACAccess BiotechnologyCACanaan PartnersCOConnecticut InnovationsELElm Street VenturesFRFrazier Life SciencesTATaiho Ventures, LLC+1 more

XOMA Royalty is a biotech royalty aggregator that acquires the economic rights to future milestone and royalty payments tied to partnered pre-commercial clinical candidates, providing sellers with non-dilutive, non-recourse funding.

BiotechFintech

Co-investorsCACatalys PacificFRFrazier Life SciencesLILightspeed Venture PartnersSASamsara BioCapitalFRFrazier Healthcare Partners

IDRx discovers, develops and delivers medicines and vaccines focused on cancer, HIV, respiratory diseases, and infectious diseases.

BiotechMedical Devices

TCTim Clacksonin

Co-investorsANAndreessen HorowitzNENextech Invest

IDRX is a regulated stablecoin backed 1:1 by the Indonesian Rupiah, letting users hold and transfer IDR value on blockchain networks for payments, trading, and Web3 financial activity.

Crypto & Web3Fintech

Co-investorsMDMDI VenturesCOCommodore Capital

ILiAD Biotechnologies is a clinical-stage biotechnology company developing vaccines and treatments for disease caused by Bordetella pertussis, with a lead candidate, BPZE1, a next-generation pertussis vaccine that has completed four Phase 2 clinical trials.

BiotechHealthtechWeston, US

KRKeith Rubin(Executive Officer, Director)William Steinkrauss(Executive Officer)KEN SOLOVAY(Executive Officer)

BoardEric Edidin(Director)Avi Naider(Director)MBMario Barro(Director)in

Imbria Pharmaceuticals develops novel cardiovascular disease treatments that target cardiac energy metabolism, with a lead drug candidate, ninerafaxstat, in clinical trials for non-obstructive hypertrophic cardiomyopathy.

BiotechDigital Health

ASAlvin Shih(CEO)inAMAlbert M. Kim(Chief Medical Officer)in

Co-investorsANAN Venture PartnersCACatalio Capital Management, LPSASanofi VenturesSVSV Health InvestorsCACatalio Capital Management

Infinimmune discovers and develops antibody therapeutics using proprietary sequencing technology and AI-powered optimization.

AI & Machine LearningBiotechMedical Devices

LHLance Hepler(Founder)inKPKatie Pfeiffer(Founder)inMichael Gibbons(Founder)inWMWyatt McDonnell(Founder)inDJdavid jaffe(Founder)inDavid Jaffe(Founder)

Co-investorsCICivilization Ventures Management, LlcPEPear VCPLPlayground GlobalAXAxial VCPAPaladin Capital GroupTRTrammell Venture Partners (TVP)

InflaRx is a biopharmaceutical company developing therapeutics that target the complement system to treat inflammatory diseases.

BiotechHealthtechJena, DE

Renfeng Guo(Founder)in

Co-investorsBABain Capital Life Sciences

Inhibikase Therapeutics is a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics for pulmonary arterial hypertension (PAH).

BiotechHealthtechAtlanta, US

MHMilton H. Werner Ph.D(Executive Officer, Director)inJoseph Frattaroli, C.P.A.(Executive Officer)Dennis Berman(Director)Gisele Dion(Director)

BoardPaul Grint, M.D.(Director)Roy Freeman M.D.(Director)

Inhibrx develops protein therapeutics, using target biology and protein engineering to create therapeutic candidates in clinical trials for conditions including sarcoma and head and neck cancer.

BiotechLa Jolla, US

MLMark Lappe(Executive Officer, Director)inBrendan Eckelman(Director)inDoug Forsyth(Director)Jon Faiz Kayyem(Director)Margery Fischbein(Director)

BoardJudith Li(Director)

Co-investorsLALAVLILilly Asia VenturesVIViking GlobalOXOxford Finance LLC

BiotechPhiladelphia, US

Philip R. Johnson, M.D.(Executive Officer, Director)inDora Mitchell(Executive Officer)LFLori Forrest(Executive Officer)Leon Moulder, Jr.(Director)BLBenjamin Lund(Director)in

BoardTomas Kiselak(Director)

Co-investorsAGAgent CapitalDCDC Investment PartnersLOLongwood FundOUOUP (Osage University Partners)PFPfizer Venture InvestmentsQUQuan Capital+3 more

IOBiotech appears to be a biotech company focused on oncology, with a founder who has extensive experience in cancer drug development and clinical advancement from roles at Roche, Eli Lilly, and leading academic cancer centers.

BiotechMedical Devices

Dr. Dhingra

Co-investorsAVAvoro Capital AdvisorsEIEIR VenturesKUKurma PartnersPIPivotal Life SciencesSASamsara BioCapitalSUSunstone Capital+3 more

Ivantis was a medical device company founded in 2007 in Irvine, California, that developed the Hydrus Microstent, a minimally invasive device for treating glaucoma during cataract surgery.

Irvine, US

DVDavid Van Meter(Executive Officer, Director)

BoardTara Butler(Director)Douglas Roeder(Director)ABAli Behbahani(Director)inRandy Alexander(Director)Thong Yuen Poon(Director)

Co-investorsASAscension VenturesFOForesite CapitalMEMemorialCare Innovation FundNENew Enterprise Associates (NEA)

Jnana has developed RAPID, a next-generation chemoproteomics platform that enables rapid discovery of small molecule drugs targeting previously inaccessible disease targets by identifying novel binding sites on complex proteins.

AI & Machine LearningBiotechDeep TechAustin, US

Joanne Dove Kotz(Founder)inJoel Barrish(Chief Scientific Officer)Donald W. Nicholson(Director)Matthew Hammond(Director)Caroline Stark Beer(Chief Business Officer)Carlo Rizzuto(Director)

Co-investorsAVAvalon BioVenturesBABain Capital Life SciencesPFPfizer Venture InvestmentsPFPfizer VenturesPOPolaris PartnersVEVersant Ventures

KalVista Pharmaceuticals is a global biopharmaceutical company that develops oral therapies for rare diseases, starting with hereditary angioedema (HAE).

BiotechHealthtech

Co-investorsFRFrazier Life SciencesLOLongwood Fund

Karyopharm is a pharmaceutical company developing drugs based on its SINE (Selective Inhibitor of Nuclear Export) technology, with medicines targeting cancers including multiple myeloma and diffuse large B-cell lymphoma.

BiotechHealthtechNewton, US

SPStuart Poulton(Executive Officer)inMichael Mano(Executive Officer)inRRReshma Rangwala(Executive Officer)inRPRichard Paulson(CEO)inStephen Mitchener(Executive Officer)inMichael Mason(Executive Officer)in

Co-investorsAVAvoro Capital AdvisorsFOForesite CapitalHEHEALTHCARE ROYALTY PARTNERS

BiotechSan Diego, US

Stephen W. Kaldor(Executive Officer, Director, Promoter)Eric Murphy(Executive Officer, Director)

BoardBret Zbar(Director)Carl Gordon(Director)MRMichael Rome(Director)in

Co-investorsFOForesite CapitalNENextech InvestVIViking GlobalJAJanus Henderson InvestorsVEVenrock Healthcare Capital PartnersVIViking Global Investors

Koloma explores and produces natural hydrogen to support global decarbonization efforts.

CleantechClimate TechDeep TechEnergyDenver, US

JKJeff Knupp(Executive Officer)inBunmi Adekore(Executive Officer, Director)PHPaul Harraka(Executive Officer)inPeter Johnson(Executive Officer, Director)

BoardCGChristian Garcia(Director)inSKShayle Kann(Director)in

Co-investorsBRBreakthrough Energy VenturesCOCongruent VenturesENEnergy Impact PartnersEVEvok InnovationsK5K5 GlobalMAMaterial Impact+7 more

LENZ Therapeutics is a pharmaceutical company developing and commercializing VIZZ™, an FDA-approved aceclidine-based eye drop for treating presbyopia, a vision condition affecting over 128 million people in the US.

BiotechHealthtechMedical DevicesSan Diego, US

JMJames McCollum(Co-founder, Board Member)ESEef SchimmelpenninkinESEvert Schimmelpennink(President and CEO)

Co-investorsALAlpha Wave GlobalRARaptor GroupRTRTW Investments L.P.SESectoral Asset ManagementVEVersant Ventures

LifeMine is a biopharmaceutical company that uses data science and advanced methods to accelerate drug discovery and develop precision medicines across therapeutic areas.

AI & Machine LearningBiotechDeep TechCambridge, US

GLGregory L. Verdine(Executive Officer, Director)GVGregory Verdine, Ph.D.

BoardHingge Hsu(Executive Officer, Director)Weiqing Zhou(Executive Officer, Director)

Co-investorsARARCH Venture PartnersGVGV (Google Ventures)AIAisling CapitalALAlexandriaBEBezos ExpeditionsBLBlue Pool Capital+7 more

MagentaMed develops the Elevate percutaneous Left Ventricular Assist Device (pLVAD), a low-profile, high-flow arterial pump for temporary mechanical circulatory support.

HardwareHealthtechMedical DevicesKadima, IL

Yosi Tuval(MSc – Co-Founder & CTO)ESEhud Schwammenthal(MD, PhD – Co-Founder & CMO)inDIDavid Israeli(MD, MBA – Chairman & CEO)in

Co-investorsALALIVE Israel HealthTech FundFRFresenius Medical Care VenturesNENew Enterprise Associates (NEA)OROrbiMedVIViking GlobalPIPitango

Mariana Oncology, a Novartis company, develops precision radioligand therapies that deliver radioisotopes to diseased cells while limiting effects on healthy tissue.

BiotechHealthtechMedical Devices

Co-investorsACAccess BiotechnologyATAtlas VentureNENextech InvestACAccess IndustriesFOForbion

Merus develops multispecific antibodies (Biclonics and Triclonics) that bind multiple cancer antigens to treat oncology indications.

BiotechMedical DevicesUtrecht, NL

TLTon Logtenberg(Executive Officer, Director)inMTMark Throsby(Executive Officer)inHLHui Liu(Executive Officer)inJCJohn Crowley(Executive Officer)inLAL. Andres Sirulnik(Executive Officer)inLBLex Bakker(Executive Officer)in

Co-investorsAVAvoro Capital AdvisorsPFPfizer Venture InvestmentsSOSofinnova Ventures

Metagenomi is a genetic medicines company developing therapies based on gene editing technologies to treat patients with serious diseases.

BiotechDeep TechHealthtechMedical DevicesBerkeley, US

BTBrian Thomas(Founder)inBrian Thomas Jillian Banfield(Founder)Jill Banfield(Founder)Jian Irish(President and CEO)

BoardAFAndrew Farquharson(Director)inJak Knowles(Director)

Co-investorsCACatalio Capital Management, LPSOSozo VenturesAGAgent CapitalFRFrazier Life SciencesHUHumboldtINInCube Ventures+5 more

Metsera was a clinical-stage biotechnology company developing injectable and oral medicines for obesity and metabolic diseases, including next-generation GLP-1 and amylin-based therapies.

BiotechHealthtechMedical DevicesNew York, US

CAClive A. Meanwell(Director)Christopher J. Visioli(Executive Officer)inBrian Hubbard(Executive Officer)inChristopher Whitten Bernard(Executive Officer, Director)Steven Marso(Executive Officer)Clive Meanwell(Founder)

Co-investorsALAlpha Wave GlobalARARCH Venture PartnersF-F-Prime CapitalGVGV (Google Ventures)SOSoftBank Vision FundVIViking Global+5 more

Moderna develops mRNA-based medicines for infectious and serious diseases using its proprietary mRNA platform and design technology.

BiotechDeep TechMedical DevicesCambridge, US

RLRobert Langer(Founder)NANoubar Afeyan, Ph.D.(Co-founder and Chairman, Moderna; CEO, Flagship Pioneering)LKLorence Kim(Executive Officer)inJRJames R. Kasinger(Executive Officer)inSHStephen Hoge(Executive Officer)inDerrick Rossi(Founder)

Co-investorsAGAglae VenturesBLBlackstone Life SciencesFLFlagship PioneeringFPFPVKHKhosla VenturesLILingotto+5 more

Napigen is a biotechnology company developing genome editing technology targeting the mitochondrial and chloroplast genomes.

AgTechBiotechWilmington, US

Co-investorsTHThe Innovation SpaceGRGrantham FoundationMAMarsBio

Nava Benefits is a technology-enabled benefits brokerage that pairs benefits consultants with AI-powered tools to help HR teams manage employee health benefits with less administrative work and lower costs.

HealthtechHR TechInsurTech

BWBrandon Weber(Founder)inDonald DeSantis(Founder)Kareem Zaki(Founder)

Co-investorsALAlumni VenturesARArchetypeAVAvid VenturesGAGaingelsGLGlynn Capital ManagementHOHomebrew+4 more

BiotechBoston, US

Virginia Burger(Executive Officer, Director)

Co-investorsPEPetriPIPillar VC

NexCure partners with health systems to build and operate outpatient treatment centers focused on delivering advanced cancer therapies such as CAR-T and T-cell engagers.

BiotechDigital HealthHealthtech

Co-investorsONOncology VenturesALAlpha Partners

Nextop IO provides a mobile content delivery network with a client-side library for iOS and Android that routes traffic through optimized proxy servers, reducing latency, improving throughput, and lowering data and battery consumption for mobile applications connecting to backend services.

Data & InfrastructureDeveloper ToolsEnterprise Software

BCBrien Colwell(CEO)in

Co-investorsY Y CombinatorANAndreessen HorowitzLILightspeed Venture PartnersNENextech Invest

NiKang Therapeutics is a clinical-stage biotechnology company developing small molecule drugs for cancer, using structure-based drug design against targets such as HIF2α, CDK2, KRAS, and SHP2.

BiotechHealthtechWilmington, CN

Yan Lou(Founder)inZhenhai Gao(President, CEO, and Secretary)H(Hong (Kelsey) Chen(Chief Financial Officer)

BoardGary Yeung(Director)Ting Jia(Director)Roderick Wong(Director)

Co-investorsECEcoR1 CapitalHBHBM Healthcare InvestmentsHBHBM PartnersLALAVLILilly Asia VenturesSASamsara BioCapital+3 more

Nimbus Engineering is a hardware company and online retailer developing energy transfer technology, including its patented Power Relay, a portable power outlet for home, office, and outdoor use.

CleantechDeep TechEnergyHardwareSan Francisco, US

Michael Gorman(Founder)in

Co-investorsFOFoothill VenturesACAccess BiotechnologyATAtlas VentureBABain Capital Life SciencesBIBiotechnology Value FundCOCommodore Capital+2 more

FuseBase is an enterprise platform for deploying and managing AI agents across teams with role-based access controls, audit trails, and integrations to CRM, Slack, Teams, and email systems.

AI & Machine LearningEnterprise SoftwareFuture of WorkSaaSCleveland, US

Pavel Sher(CEO)Aaron Adsit(CRO)Denis Kibalko(CTO)

Co-investorsPRPre-Seed to SucceedYEYellow Rocks!ACAccess BiotechnologyATAtlas VentureBABain Capital Life SciencesBIBiotechnology Value Fund+3 more

Nimbus Therapeutics is a biotechnology company that designs precision small molecule medicines using a computational, multidisciplinary drug discovery approach.

AI & Machine LearningBiotechDeep TechHealthtech

Co-investorsACAccess BiotechnologyATAtlas VentureBABain Capital Life SciencesDEDementia Discovery FundGVGV (Google Ventures)LILightstone Ventures+4 more

NorthLinks Bio is a clinical-stage biopharmaceutical company developing HEX17, an intranasal antiviral designed to prevent respiratory virus infections by blocking viral entry at the nasal epithelium.

BiotechHealthtechSt Andrews, GB

FCFanny Cavalié(Chief Executive Officer)in

Nucleix is a healthcare company developing diagnostic technology based on DNA/nucleic acid analysis for cancer detection.

BiotechDigital HealthHealthtechMedical Devices

EFEli Frydman(President EMEA)

Co-investorsGEGefen CapitalOROrbiMedAUAurum Ventures MKIBLBlackRockLILilly Asia VenturesLYLYFE Capital+1 more

Oncology Ventures is a cancer-focused venture capital fund that invests in healthcare technology startups related to oncology care.

AI & Machine LearningBiotechDigital HealthHealthtech

BFBen Freeberg(Founder, Managing Partner)inJay Freeberg(Chief Financial Officer)

Co-investorsSASandwich CapitalALAlleyCorpCACanaan PartnersCOConcord Health PartnersCVCVS Health VenturesFOForbion+5 more

Developing biologic therapies for autoimmune disorders; acquired by Merck for $1.85B in 2021.

BiotechCambridge, US

JVJo Viney(Executive Officer)RKRahul Kakkar(Executive Officer, Director)inACAnthony Coyle(Executive Officer, Director)inChristopher Fuglesang(Director)Donald Frail(Director)Daniel Becker(Director)

Co-investorsACAccess BiotechnologyJDJDRF T1D FundMIMission BiocapitalSRSR One Capital ManagementPOPolaris PartnersVEVersant Ventures

The Faculty of Pharmacy and Biochemistry offers pharmacy and biochemistry degree programs, including a Pharmacy programme in English aligned with EU Directive 2005/36/EC for EU/EEA registration.

EdTech

Co-investorsVEVesna AdvisorsNENextech InvestTHThe Column Group

Pinnacle Medicines develops oral peptide-based therapies designed to deliver antibody-like efficacy in pill form for patients with chronic diseases.

BiotechDigital HealthDoylestown, US

CSChengzao Sun(Founder)inSandeep Somani(Founder)in

Co-investorsFOForesite CapitalQUQuan CapitalLALAVOROrbiMedVEVenrock

Planted Solar operates a vertically integrated solar platform that links site origination, design, permitting, construction, and operations, using high-density terrain-following arrays and precision field machines to reduce land use and speed deployment.

CleantechClimate TechConstruction TechEnergyOakland, US

Richard Erb(Founder)in

Co-investorsBRBreakthrough Energy VenturesPIPiva CapitalTETeam Builder VenturesKHKhosla VenturesPEPETRONAS Ventures

Plantible Foods redesigns the food supply chain to advance health for people and the planet.

AgTechBiotechFoodTechImpact & Social GoodSan Marcos, US

TMTony Martens(Founder & CEO)inMaurits Van de Ven(Founder)in

BoardAlan Chen(Director)

Co-investorsASAstanor VenturesCECerity Partners VenturesDODoon CapitalFTFTW VenturesGOGood FriendsLELerer Hippeau+8 more

PMV Pharma is a precision oncology company developing therapies that selectively target mutant p53 to treat cancers whose tumors carry p53 gene mutations.

BiotechHealthtechLongevityCranbury, US

DHDavid H. Mack, Ph.D.(Founder)inDavid Mack(Executive Officer, Director)Arnold Levine(Co-Founder & Member, Scientific Advisory Board)David H. Mack(Co-Founder, President & CEO)Thomas Shenk(Co-Founder)Deepika Jalota(Chief Development Officer)

Co-investorsAVAvoro Capital AdvisorsNENextech InvestOUOUP (Osage University Partners)VIViking GlobalWEWellington ManagementOROrbiMed

Poplar Therapeutics is a company whose website provides informational content; based on its name it operates in therapeutics/biotech, though the available page (a privacy policy) does not describe its specific products or focus.

Biotech

Co-investorsSRSR One Capital ManagementVIVida Ventures

Acquired by Genmab in April 2024.

Co-investorsB B Capital GroupB4B4 CapitalHOHongShan Capital GroupLALAVLILifeSci Venture PartnersLILilly Asia Ventures+2 more

UCB (UCB SA/NV) is a publicly listed biopharmaceutical company focused on research and development of medicines for defined patient populations.

BiotechHealthtechCambridge, US

DADouglas A. Treco(Executive Officer, Director)Kerry Black(Executive Officer)inJean-Christophe Tellier(Chief Executive Officer & Chairman of the Executive Committee)Sandrine Dufour(Executive Vice President, Chief Financial Officer)Jean Luc Fleurial(Executive Vice President, Chief Human Resources Officer)Fiona du Monceau(Executive Vice President, Chief Commercial Officer)

Co-investorsLILightstone VenturesNENew Enterprise Associates (NEA)MOMorgenthaler

Radence offers members a preventive healthcare service built around early-detection diagnostics, using proprietary protocols across genomics, serum biomarkers, imaging, and other testing to screen for cancer, neurodegenerative, cardiovascular, and metabolic disease.

AI & Machine LearningDigital HealthHealthtech

David Medvedeff(CEO)inWuhong Li(Chief Technology Officer)inJulie Chen MDinJulie Chen(Chief Medical Officer)Sarah Pesce(Chief Operating Officer)Page Ikeda(Chief Product Officer)

Reframe helps developers and builders deliver construction projects—from small multi-unit builds to community-scale developments—with more predictable timelines and outcomes.

Climate TechConstruction TechPropTechRobotics

ASAaron Small(Founder)in

Co-investorsCUCubit CapitalENEnergy Impact PartnersFOFoundamentalGLGlobal BrainSEService Provider CapitalVOVoLo Earth Ventures+2 more

Regulus is a Japanese company working on recruiting automation software.

Future of WorkHR Tech

Max Koenig

Co-investors50500 GlobalSISierra VenturesCACanaan Partners IsraelF2F2 Venture CapitalNENew Enterprise Associates (NEA)VIVivo Capital

Boston-based biotech developing drugs against the 'dark genome'/repeatome for autoimmune disease, cancer and neurodegeneration.

Benjamin Greenbaum(Founder)David Ting(Founder)Rosana Kapeller(Founder)

Co-investorsANAndreessen HorowitzARARCH Venture PartnersGVGV (Google Ventures)LULuma GroupSASanofi VenturesABAbingworth+11 more

Satsuma Pharmaceuticals develops therapeutics for the acute treatment of migraine, including an approved dihydroergotamine nasal powder product (Atzumi/STS101).

BiotechHealthtechMedical DevicesSouth San Francisco, US

JKJohn Kollins(Executive Officer, Director)Tadayoshi Iwashima(Executive Officer)TBThomas B. King(President and Board Director)inRJRob Janosky(Chief Commercial Officer)TOTom O'Neil(Chief Financial Officer)inDavid Prichard(Chief Operating Officer)

Co-investorsOUOUP (Osage University Partners)VIVivo CapitalWEWellington ManagementLULumira VenturesRERed Tree VentureSBSBI Investment

SeaGen develops automated robots that monitor aquatic ecosystems and remove pollutants while supporting the growth of beneficial species like seaweed to improve food and water security and reduce atmospheric carbon.

CleantechClimate TechRobotics

Co-investorsAEAera VCRIRidgeback CapitalALAlly Bridge GroupT.T. Rowe Price

Secretome Therapeutics is a biotechnology company advancing therapeutic programs through research, development, and clinical operations.

BiotechHealthtechDallas, US

ANGELA SHEN(Director)HENRIK RASMUSSEN(Director)VINEET JINDAL(Executive Officer, Director)SUNJAY KAUSHAL(Director)WILLIAM NILAND(Director)

BiotechCharlestown, US

ESEric Stern(Executive Officer, Director, Promoter)AVAleksandar Vacic(Executive Officer, Promoter)inJames Parker Cassidy(Director)Scott Yaphe(Director)Steven E. Lufkin(Executive Officer, Director)Michael Rubin(Director)

Co-investorsSASands Capital Ventures

Serapha Bio is a biotechnology company.

Biotech

Co-investorsVIVivo CapitalRTRTW Investments L.P.

Sidera Bio is a biotechnology company using human genetics to develop new medicines for patients.

Biotech

Co-investorsCACatalio Capital Management, LPFOForbionNONovo Holdings

A biopharmaceutical company that discovers, develops, and delivers medicines and vaccines, with research and development across respiratory, immunology and inflammation, oncology, HIV, and infectious diseases.

BiotechHealthtechMedical DevicesSan Francisco, US

Co-investorsCACapital Midwest FundFRFrazier Life SciencesLOLongitude CapitalVIVivo CapitalOXOxford Finance LLC

BiotechDigital HealthMedical DevicesSeattle, US

PAPeter A. Thompson(Executive Officer, Director)in

Co-investorsECEcoR1 CapitalPOPontifax Venture CapitalUSUS Venture PartnersALAlexandriaNENextech InvestOROrbiMed

Slate Medicines is a clinical-stage biotechnology company.

BiotechMedical DevicesBoston, US

Sara Pacheco(Executive Officer)Neil Buckley(Executive Officer, Director)inGOGregory Oakes(Chief Executive Officer and Board Director)in

BoardTim Lohoff(Director)CXCindy Xiong(Director)inALAndrew Levin(Director)

Co-investorsFOForesite CapitalVEVenrock

Somatus provides value-based, integrated kidney care and a congestive heart failure management solution for patients, providers, and health plan partners.

Digital HealthHealthtechMclean, US

IOIkenna Okezie(Executive Officer, Director)inAlexander Houlday(Executive Officer)inStacey Queen-Pyndell(Executive Officer)LRLarry Renfro(Interim President & CEO)

BoardAnna Haghgooie(Director)AWAnthony Welters(Director)

Co-investorsFLFlare Capital PartnersOPOptum VenturesHEHealthQuest CapitalBLBlue Venture FundsDEDefy PartnersLOLongitude Capital+7 more

SonoThera is developing a nonviral, non-invasive gene delivery technology that uses ultrasound and microbubbles (ultrasound-mediated delivery) to deliver genetic payloads to targeted sites in a redosable way.

BiotechDeep TechDigital HealthHealthtechSouth San Francisco, US

KGKenneth Greenberg(Co-Founder, President & CEO)in

Co-investorsVIVida VenturesLELeaps by BayerARARCH Venture PartnersFOFoothill VenturesILIllumina VenturesMEMedical Excellence Capital+8 more

Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company developing targeted therapies for cardiometabolic disease.

BiotechHealthtechMedical DevicesPortland, US

RJRobert Jacks(Executive Officer, Director)inDavid Aaron Katz(Executive Officer, Director)

BoardJRJonathan Root(Director)inNONiall O'Donnell(Director)inZSZach Scheiner(Director)inKVKlaus Veitinger(Director)in

Co-investorsOROrbiMedRIRiverVest Venture PartnersUSUS Venture PartnersFOForbion

Star Therapeutics develops treatments aimed at addressing real-world patient needs.

BiotechSouth San Francisco, US

ARAdam Rosenthal(Founder & CEO)inNSNancy Stagliano(Director)inMichelle Carpenter(Executive Officer)Sandip Panicker(Executive Officer)SRScott Robertson(Executive Officer)inGary Patou(Executive Officer)in

Co-investorsFRFrazier Life SciencesOROrbiMedSASanofi VenturesSOSofinnova VenturesVIViking GlobalAGAgent Capital+11 more

Stylus Medicine develops in vivo genetic medicines using engineered recombinases, with initial focus on creating CAR-T therapies delivered via lipid nanoparticles for oncology, autoimmune, and genetic diseases.

BiotechDigital HealthMedical Devices

Michael C. Bassik, Ph.D.(Scientific Founder)ENEmile Nuwaysir, Ph.D.(Chairman & Chief Executive Officer)inJFJason Fontenot, Ph.D.(Chief Scientific Officer)Ami Bhatt(Founder)Lacramioara Bintu(Founder)Michael Bassik(Founder)

Co-investorsBRBrainstorm VenturesCACAL InnovationCACalifornia Innovation FundKHKhosla VenturesNENeva Sgr.TATachyon Ventures+1 more

Synapticure provides virtual care services for individuals and families with neurodegenerative conditions, offering access to expert-led care, cutting-edge treatments, clinical trials, and wraparound support across all 50 US states through a network of local partners.

AI & Machine LearningDigital HealthHealthtechChicago, US

PWPeter Wallach(Founding CEO, Founder)BWBrian Wallach(Founder)inMDMartina de Majo(Founder)inSASandra Abrevaya(Co-Founder, Chief Executive Officer)inJLJason Langheier(Co-Founder, Board Co-Chair)inJHJaimie Hatcher-Martin(Dr.)

Co-investorsGEGeneral AtlanticSVSV AngelB B Capital GroupB4B4 CapitalBEBeaconsfield CapitalCVCVS Health Ventures+15 more

Synthego develops CRISPR gene-editing and molecular diagnostics products, including custom CRISPR editors in mRNA or protein formats, base editors, and cell-free protein and RNA production systems.

BiotechDeep TechHealthtechMedical DevicesRedwood City, US

PJPaul John Dabrowski(Executive Officer, Director)MJMichael Jakub Dabrowski(Executive Officer, Director)CCCraig Christianson(CEO)inAlex Pesch(Founder)Michael Dabrowski(Founder)Paul Dabrowski(Founder)

Co-investorsAAAAF Management Ltd.AMAME Cloud VenturesDEDeclaration PartnersFOFounders FundKHKhosla VenturesMEMenlo Ventures+11 more

Synthekine is a clinical-stage biotechnology company using protein engineering platforms to develop cytokine-based immunotherapies designed to preserve therapeutic efficacy while avoiding toxicities linked to cytokine pleiotropy.

BiotechHealthtech

K. Christopher Garcia(Founder)SMSusan Molineaux(CEO)inMartin Oft(Chief Scientific Officer)inNaiyer Rizvi(Chief Medical Officer)inGregory(Chief Technical Officer)Geoff(Chief Business Officer)

Co-investorsSASamsara BioCapitalTHThe Column GroupBABain Capital Life SciencesCACanaan PartnersTCTCG CrossoverDEDeerfield Management Company+2 more

T-knife Therapeutics is a biopharmaceutical company developing T cell therapies to treat cancer, with an initial focus on solid tumors.

BiotechHealthtechBerlin, DE

EKElisa Kieback(Co-founder & Chief Technology Officer)inTBThomas Blankenstein(Scientific Founder)TSThomas Soloway(Chief Executive Officer)CLCamille Landis(Chief Business Officer / Chief Financial Officer)inPeggy Sotiropoulou(Chief Scientific Officer)in

Co-investorsANAndera PartnersVEVersant VenturesEQEQT Life SciencesSISixty Degree CapitalFIFidelity Investments

HealthtechLexington, US

Michael Cima, Ph.D.(Director)RDRahul Dhanda(Senior Vice President, Corporate Development)inJMJohn McDonough(Chief Executive Officer)inTom Lowery, Ph.D.(Chief Scientific Officer)Michael Gibbs, Esq.(Vice President and General Counsel)Joanne Spadoro, Ph.D.(Chief Operating Officer)in

Co-investorsAIAisling CapitalAPAPERTURE Venture PartnersINIn-Q-TelARArcus VenturesFLFlagship VenturesFLFlybridge Capital Partners+2 more

Tasso develops diagnostic testing devices and platforms for home use, enabling patients to perform health monitoring and inform clinical decisions outside traditional healthcare settings.

Digital HealthHealthtechMedical DevicesSeattle, US

BCBen Casavant(Co-Founder and Chief Executive Officer)inEBErwin Berthier(Co-Founder and Chief Technology Officer)inALAlan Levy(Director)

BoardElizabeth Hambrecht(Director)PCPaul Conley(Director)in

Co-investorsFOForesite CapitalJ2J2 VenturesMEMerck Global Health Innovation FundMSMSD Global Health Innovation FundOMOMX VenturesTETechstars+3 more

TeraPore develops nanofiltration products based on tunable self-assembled block copolymer technology to address complex separation challenges in biopharmaceutical production and semiconductor manufacturing.

Advanced ManufacturingBiotechDeep TechNew MaterialsSemiconductorsSouth San Francisco, US

RMRachel M. Dorin(Executive Officer, Director)inRDRachel Dorin(CTO and Founder)inMani Krishnan(President and CEO)in

BoardStuart Berkowitz(Director)DSDavid Seldin(Director)DMDavid Michael(Director)in

Co-investorsANAnzu PartnersARArtiman Ventures

Terremoto Biosciences is a clinical-stage biotech developing precision therapies for oncology and genetic diseases using lysine-targeted covalent chemistry.

BiotechDeep TechSouth San Francisco, US

Grace Lu(Executive Officer)James Christensen(Executive Officer, Director)Charles Baum(Executive Officer, Director)in

BoardMichael Goller(Director)RHReid Huber(Director)inPTPeter Thompson(Director)in

Co-investorsECEcoR1 CapitalOROrbiMedNONovo HoldingsTHThird Rock Ventures

Terrestrial is developing the Tacterra microarray patch (MAP) platform, which uses dissolvable tips made from biomaterials to deliver therapies such as GLP-1 through the skin without injections.

BiotechDeep TechMedical Devices

RSRachel Sha(CEO)in

Co-investorsGLGlobal Health Investment CorporationTHThe Engine VenturesULUlu Ventures

Thriveworks provides therapy and psychiatric medication management services, helping clients find providers and book sessions, with insurance accepted.

Digital HealthHealthtechMedia & EntertainmentMental HealthWellness & Fitness

ACAnthony Centore(Executive Officer, Director)AJ Centore(Founder)inDaniel Frogel, MDinJon Santemma(Executive Officer, Director)Terry Wang(Director)David Kim(Director)

Co-investorsRORogue Insight CapitalTRTRANSFORMATION CAPITALWEWellington ManagementFIFidelity InvestmentsREREDMILE

Plasma is a financial technology company offering Plasma One, a stablecoin-based account and Visa card that supports USD₮ transfers, cashback, and yield through third-party DeFi protocols.

Crypto & Web3FintechLondon, GB

Co-investors1/1/1 Capital6T6th Man VenturesBEBeni Venture CapitalIMImpossible FinanceMEMercury FundMIMirana Ventures+12 more

TORL BioTherapeutics develops antibody-drug conjugates (ADCs) targeting Claudin 6 (CLDN6) for the treatment of solid tumors such as ovarian, lung, endometrial, and testicular cancers.

BiotechHealthtechCulver City, US

Dave LicatainAran Maree M.D.inMark Alles(Executive Officer, Director)Mark Attanasio(Director)David Licata(Executive Officer, Director)Neil O'Brien(Director)

Co-investorsOCOCV PartnersCOCowen Healthcare InvestmentsGOGoldman SachsPEPerceptive Xontogeny VentureVEVertex Ventures HC

A company focused on developing clinical treatments aimed at improving patient outcomes.

BiotechHealthtechMedical DevicesBoston, US

DSDavid Southwell(Executive Officer, Director)inRobert Crane(Executive Officer)

BoardLHLea Hachigian(Director)SKSteve Kraus(Director)inCMCampbell Murray(Director)inHSHannes Smarason(Director)in

Co-investorsASAstellas Venture Management LLCBEBessemer Venture PartnersGVGV (Google Ventures)LOLongwood Fund6 6 Dimensions CapitalPIPitango

Ventus AI is an enterprise automation platform offering AI agents ("AI teammates") that operate inside existing systems—desktop apps, web portals, and legacy software—without API integrations to automate complex business workflows, handling MFA, CAPTCHAs, and phone calls.

AI & Machine LearningEnterprise SoftwareHealthtechCasa Grande, US

Maran Vedamanikam(CEO and Manager)Peter Qian(Co-founder & CEO)Vincent Lu(Co-founder & CTO)

Co-investorsSASamsung NextANAndreessen HorowitzWNWndrCoALAlexandriaBIBiotechnology Value FundCACasdin Capital+5 more

Ventus discovers and develops small-molecule medicines using its proprietary ReSOLVE platform, focused on structure-based drug discovery.

AI & Machine LearningBiotechDeep TechHealthtechWaltham, US

Judith Lieberman(Co-Founder)DKDaniel Koerwer(Executive Officer)inMCMichael Crackower(Executive Officer)inZachary McNealy(Executive Officer)Marcelo Bigal, M.D., Ph.D.(President and Chief Executive Officer)

BoardJRJosh Resnick(Director)in

Co-investorsANAndreessen HorowitzGVGV (Google Ventures)SOSoftBank Vision FundVEVersant VenturesALAlexandriaBIBiotechnology Value Fund+3 more

Verdiva Bio is a biotechnology company focused on drug development.

BiotechHealthtech

JHJane Hughes(Chief Scientific Officer)inKFKhurem Farooq(Founder)in

Co-investorsGEGeneral AtlanticOROrbiMedFOForbion

Cambridge, MA biotech developing single-course in vivo base editing medicines to permanently lower cardiovascular disease risk.

BiotechCambridge, US

Andrew Ashe(Executive Officer)SKSekar Kathiresan(Founder)inABAndrew Bellinger(Executive Officer)Kiran Musunuru(Founder)

BoardJohn Evans(Director)APAnthony Philippakis(Director)in

Co-investorsARARCH Venture PartnersF-F-Prime CapitalGVGV (Google Ventures)VEvenBio PartnersWEWellington ManagementCACasdin Capital+3 more

Transforming the lives of patients through a functional cure for Type 1 Diabetes

BiotechSan Diego, US

Brittany Bradrick(Executive Officer)Anne Sandan(Executive Officer)Elizabeth Bui(Executive Officer)Steve White(Executive Officer)HFHoward Foyt(Executive Officer)inKevin D'Amour(Executive Officer)in

Co-investorsARArtis VenturesATATEL VenturesBABain Capital Life SciencesSASanderling VenturesTHThe Vertical GroupJOJohnson & Johnson Innovation – JJDC+1 more

Vilya designs novel macrocycles using AI and computational biology to create medicines that don't exist in nature.

AI & Machine LearningBiotechDeep Tech

DBDavid Baker(Founder)PSPatrick Salveson, PhD(Co-Founder, CTO)AMAdam Moyer, PhD(Co-Founder, VP of Molecular Design)DBDavid Baker, PhD(Nobel laureate, Co-Founder, Director, IPD UW, Prof. Biochemistry)GBGaurav Bhardwaj, PhD(Co-Founder, UW, Asst. Prof. Medicinal Chemistry)LSLance Stewart, PhD, MBA(Co-Founder, CSO & COO, IPD)

Co-investorsARARCH Venture PartnersMAMadrona Venture GroupMEMenlo VenturesNVNVIDIAALAltitude Ventures Management, LlcALAlumni Ventures+10 more

WhiteSwell is a medical device company developing innovative devices in the healthcare sector.

HealthtechMedical Devices

Ric Cote(Board Member)

Co-investorsINInCube Ventures

Windward delivers AI-powered operational intelligence for maritime security and commercial applications, fusing behavioral analytics and multi-sensor data to detect threats and opportunities.

AI & Machine LearningData & InfrastructureDefense TechTel Aviv

Amiad Daniel(Executive Officer, Director)MPMatan Peled(Founder)inAmi Daniel(Founder)

BoardDov Gatmon(Director)Patrick Poon(Director)ESEden Shochat(Director)in

Co-investorsALAlephFTFTV CapitalTHThompson Hutton, LLCJAJanus Henderson InvestorsPIPivotal Life SciencesQIQiming Venture Partners+3 more

Windward Bio is a clinical-stage biotechnology company developing long-acting monoclonal and bispecific antibodies for serious immunological conditions such as asthma, COPD, and dermatological diseases.

BiotechHealthtech

Co-investorsOROrbiMedQUQuan CapitalSASanofi VenturesSRSR One Capital ManagementJAJanus Henderson InvestorsNONovo Holdings+3 more